Literature DB >> 31768206

Enhanced Efficiency of 13C Dynamic Nuclear Polarization by Superparamagnetic Iron Oxide Nanoparticle Doping.

Peter Niedbalski1, Christopher R Parish1, Qing Wang1, Zahra Hayati2, Likai Song2, Zackary I Cleveland3,4, Lloyd Lumata1.   

Abstract

Attainment of high NMR signal enhancements is crucial to the success of in vitro or in vivo hyperpolarized NMR or imaging (MRI) experiments. In this work, we report on the use of a superparamagnetic iron oxide nanoparticle (SPION) MRI contrast agent Feraheme (ferumoxytol) as a beneficial additive in 13C samples for dissolution dynamic nuclear polarization (DNP). Our DNP data at 3.35 T and 1.2 K reveal that addition of 11 mM elemental iron concentration of Feraheme in trityl OX063-doped 3 M [1-13C] acetate samples resulted in a substantial improvement of 13C DNP signal by a factor of almost 3-fold. Concomitant with the large DNP signal increase is the narrowing of the 13C microwave DNP spectra for samples doped with SPION. W-band electron paramagnetic resonance (EPR) spectroscopy data suggest that these two prominent effects of SPION doping on 13C DNP can be ascribed to the shortening of trityl OX063 electron T 1 as explained within the thermal mixing DNP model. Liquid-state 13C NMR signal enhancements as high as 20,000-fold for SPION-doped samples were recorded after dissolution at 9.4 T and 297 K, which is about 3 times the liquid-state NMR signal enhancement of the control sample. While the presence of SPION in hyperpolarized solution drastically reduces 13C T 1, this can be mitigated by polarizing smaller aliquots of DNP samples. Moreover, we have shown that Feraheme nanoparticles (~30 nm in size) can be easily and effectively removed from the hyperpolarized liquid by simple mechanical filtration, thus one can potentially incorporate an in-line filtration for these SPIONS along the dissolution pathway of the hyperpolarizer-a significant advantage over other DNP enhancers such as the lanthanide complexes. The overall results suggest that the commercially-available and FDA-approved Feraheme is a highly efficient DNP enhancer that could be readily translated for use in clinical applications of dissolution DNP.

Entities:  

Year:  2017        PMID: 31768206      PMCID: PMC6876865          DOI: 10.1021/acs.jpcc.7b06408

Source DB:  PubMed          Journal:  J Phys Chem C Nanomater Interfaces        ISSN: 1932-7447            Impact factor:   4.126


  42 in total

1.  Dynamic nuclear polarization polarizer for sterile use intent.

Authors:  Jan H Ardenkjaer-Larsen; Andrew M Leach; Neil Clarke; John Urbahn; Denise Anderson; Timothy W Skloss
Journal:  NMR Biomed       Date:  2011-03-18       Impact factor: 4.044

2.  Assembly and performance of a 6.4 T cryogen-free dynamic nuclear polarization system.

Authors:  Andhika Kiswandhi; Peter Niedbalski; Christopher Parish; Qing Wang; Lloyd Lumata
Journal:  Magn Reson Chem       Date:  2017-06-21       Impact factor: 2.447

3.  Influence of Dy3+ and Tb3+ doping on 13C dynamic nuclear polarization.

Authors:  Peter Niedbalski; Christopher Parish; Andhika Kiswandhi; Leila Fidelino; Chalermchai Khemtong; Zahra Hayati; Likai Song; André Martins; A Dean Sherry; Lloyd Lumata
Journal:  J Chem Phys       Date:  2017-01-07       Impact factor: 3.488

4.  Dissolution DNP-NMR spectroscopy using galvinoxyl as a polarizing agent.

Authors:  Lloyd L Lumata; Matthew E Merritt; Craig R Malloy; A Dean Sherry; Johan van Tol; Likai Song; Zoltan Kovacs
Journal:  J Magn Reson       Date:  2012-11-19       Impact factor: 2.229

5.  Effect of electron spin dynamics on solid-state dynamic nuclear polarization performance.

Authors:  Ting Ann Siaw; Matthias Fehr; Alicia Lund; Allegra Latimer; Shamon A Walker; Devin T Edwards; Song-I Han
Journal:  Phys Chem Chem Phys       Date:  2014-09-21       Impact factor: 3.676

6.  Electron spin resonance studies of trityl OX063 at a concentration optimal for DNP.

Authors:  Lloyd Lumata; Zoltan Kovacs; A Dean Sherry; Craig Malloy; Stephen Hill; Johan van Tol; Lu Yu; Likai Song; Matthew E Merritt
Journal:  Phys Chem Chem Phys       Date:  2013-06-28       Impact factor: 3.676

7.  Physicochemical properties of ferumoxytol, a new intravenous iron preparation.

Authors:  V S Balakrishnan; M Rao; A T Kausz; L Brenner; B J G Pereira; T B Frigo; J M Lewis
Journal:  Eur J Clin Invest       Date:  2009-04-23       Impact factor: 4.686

8.  Detecting tumor response to treatment using hyperpolarized 13C magnetic resonance imaging and spectroscopy.

Authors:  Sam E Day; Mikko I Kettunen; Ferdia A Gallagher; De-En Hu; Mathilde Lerche; Jan Wolber; Klaes Golman; Jan Henrik Ardenkjaer-Larsen; Kevin M Brindle
Journal:  Nat Med       Date:  2007-10-28       Impact factor: 53.440

Review 9.  Emerging applications for ferumoxytol as a contrast agent in MRI.

Authors:  Mustafa R Bashir; Lubna Bhatti; Daniele Marin; Rendon C Nelson
Journal:  J Magn Reson Imaging       Date:  2014-06-30       Impact factor: 4.813

10.  MRI of tumor-associated macrophages with clinically applicable iron oxide nanoparticles.

Authors:  Heike E Daldrup-Link; Daniel Golovko; Brian Ruffell; David G Denardo; Rosalinda Castaneda; Celina Ansari; Jianghong Rao; Grigory A Tikhomirov; Michael F Wendland; Claire Corot; Lisa M Coussens
Journal:  Clin Cancer Res       Date:  2011-07-26       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.